Rega marang bathi mangsa ngarep: Nephros Corp (NEPH)

The forward P/E ratio of Nephros, Inc. (NEPH) demonstrates stable revenue from the regular sale of replacement filters for operating systems. Pragmatic management focuses on capturing the water sterilization niche, while strict FDA standards block the entry of new players. Consequently, 12.20 becomes the new value of the indicator, confirming market expectations for the capitalization of Nephros, Inc. (NEPH) considering the cost of capital.

nephros.com - Pangali Forward P/E NEPH (periode 04.07.2022 - 13.11.2026)

Nephros Corporation - rincian analitis lan metrik utama (NEPH)

- kuotasi lan prakiraan analis:

Rega saham Nephros|NEPH - Rata-rata rega prakiraan

- indikator kapitalisasi bursa perusahaan:

Nilai pasar Nephros Inc|NEPH - Nilai Perusahaan Nalika Diakuisisi Penuh

- data ekuitas miturut neraca:

Nilai Akuntansi saben Saham Nephros|NEPH - Kapitalisasi Buku|Rasio Kapitalisasi Pasar marang Nilai Buku nephros.com|NEPH - Gunggung Aset Perusahaan

- data utang lan likuiditas:

- rincian asil keuangan lan kelipatan valuasi:

NEPH - Bathi sawise mbayar pajeg|Bathi sing dikarepake Nephros, Inc.|NEPH - Pangali rega marang bathi|Pangali Forward P/E Nephros Corp|NEPH - Rega marang bathi kanthi panyesuaian wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Nephros Inc|NEPH - Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi|Bathi resik saben saham (EPS TTM) Nephros|NEPH - Bathi saben saham sajroning taun lumaku|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan nephros.com|NEPH - Tambahing bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Nephros, Inc.

- indikator volume dodolan lan pendapatan:

NEPH - Total pendapatan perusahaan|Prakiraan pendapatan perusahaan Nephros|NEPH - Koefisien rega marang pendapatan|Multiplikator forward rega marang pendapatan Nephros Inc

Analisis fundamental perusahaan:Nephros

Nephros, Inc. (NEPH) is scaling the delivery of high-precision filtration systems for the US medical and food sectors, aiming for dominance in the building engineering equipment niche. The company's forward P/E ratio compares the current market value of the stock with expected earnings, allowing investors to use this chart to quickly assess fair value amidst inter-quarter reporting gaps and risks of declining operational efficiency.

Pesaing Nephros, Inc. (NEPH)